Can a scan show whether your heart plaque is growing or shrinking?

Scans can now measure heart plaque directly instead of estimating your risk. Measuring what you have is the strong part; tracking whether it changed is not yet reliable.

79 min · 3 min readExpert: Dr. Campbell Rogers|Watch episode|
Editorial profile:Coronary imagingPlaque measurement

What this episode covers

  • A CT scan plus computer analysis can now measure how much plaque is in your heart arteries, and what it is made of, rather than estimating your risk from blood markers.
  • Many people who have a heart attack had no warning symptoms beforehand, and a calcium score of zero cannot see soft plaque at all.
  • The headline claim of a 48% reduction over 16 months is less solid than it sounds: two other analysis tools read the same scans and disagreed, including on the direction.

Confidence in this episode

Everything about how much to believe this episode, in one place.

Overall confidence:Mixed

Strong confidence in what the scan can measure and in the calcium-score point. Low confidence in the headline 48% figure, which two other tools contradicted, and in whether acting on these scans prevents heart attacks.

Evidence at a glance
Mechanistic evidenceStrong
Human clinical evidenceModerate
Clinical certaintyLow
✓ Consistent with established evidence
  • Coronary CT angiography is already the preferred test in guidelines for people with symptoms.
  • A calcium score of zero means low risk, but it cannot see non-calcified plaque.
  • Many people who have a heart attack had no warning symptoms beforehand, which is why symptoms alone are an imperfect way to identify risk.
  • Lowering LDL reduces heart attacks, which is well established across decades of trials.
Less certain
  • That the 48% reduction is real. Three tools read the same scans and disagreed on the amount, and even on the direction of change.
  • That using this scan leads to fewer heart attacks. The evidence currently runs through LDL as a stand-in.
  • How quickly plaque genuinely changes, and how long to wait between scans.
  • Whether scanning people without symptoms benefits them; it is not currently indicated or covered.

Why it matters

Most heart-disease decisions are made from a risk estimate: your cholesterol, your age, your family history. Two people with the same numbers can have completely different arteries, and until recently there was no way to tell which one you were without an invasive procedure. Being able to look is a real change. What it does not yet tell you is whether looking makes you live longer, and that gap is where the enthusiasm runs ahead of the evidence.

What stands out

  • Many heart attacks arrive without warning — many people who have one never had warning symptoms beforehand, which is why symptoms alone are an imperfect way to identify risk (the speaker's figure).
  • A calcium score of zero is not a clean bill of health — it means low risk, but soft plaque is invisible to it (established).
  • The tools disagree with each other — the host had his own scans read by three systems; they agreed he had little plaque but differed on the amount and on whether it rose or fell (his own disclosure).
This is one of multiple expert perspectives. The full topic combines them into clear guidance.Explore full topic →

Best-supported action

The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.

Where to start

Small low-friction starters covering the main moves from this episode.

  • Ask what your calcium score actually rules out.
  • Ask whether a scan result would change your treatment.
  • If you do rescan, use the same centre and the same machine.

Other supported actions

Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.

  • If you have symptoms that could be heart-related, ask about a CT angiogram — guidelines already rank it above older stress tests.Strong evidence
  • Don't treat a calcium score of zero as proof you have no plaque; it means low risk, not no disease.Strong evidence
  • If you're considering a scan without symptoms, know it isn't currently indicated or covered, and ask what you would do differently with the result.Moderate evidence

Full context, impact ratings, and timing — available in related topics

Questions to take to your doctor

Questions worth asking based on this episode
  • Given my symptoms and risk factors, would a CT angiogram change what we do?
  • Given my calcium score, what does it rule out and what does it not?
  • Given my results, what would we do differently that we aren't already doing?

Full doctor prep with ranked questions available in the full topic page

This is one expert perspective. The full topic ranks actions across multiple experts.Explore full topic →

Context

How this expert sees it

Dr. Campbell Rogers approaches this through the lens of clinical evidence and practical application. The emphasis is on what you can actually change, not just what the science shows.

What we don't know yet

This episode does not show that having an AI plaque scan leads to fewer heart attacks. That evidence does not exist yet, and the speaker says so: the link runs through lowering LDL, which is well proven to reduce events, rather than through outcomes measured from using the tool itself.

The headline figure deserves care. The host had the same scans analysed by three different systems. They agreed he had a small amount of plaque, but disagreed on how much, and even on whether it had gone up or down. He names his own bias toward the result he liked. At low plaque levels over 16 months, the change may sit within the noise.

The speaker is chief medical officer at the company whose technology is the subject, and the episode uses the host's own scan as the demonstration. He is unusually careful about what is not yet proven, and states that scanning is not currently indicated or covered for people without symptoms. The episode also carries several unrelated product advertisements.

Overall evidence profile: an established imaging technology with prospective validation against an invasive gold standard and a place in the guidelines for symptomatic patients, plus a surrogate outcome (LDL lowering), not yet evidence that using it prevents heart attacks.

Where people go wrong

  • Reading a calcium score of zero as proof you have no heart disease.It means your risk is low, but non-calcified plaque does not show up on it at all.
  • Treating a single change between two scans as a reliable measure of progress.At low plaque levels the tools disagreed even on direction, and there is little data on how fast plaque really changes.

What to expect over time

  • Before any scanThe useful question is whether the result would change your treatment. If it would not, the scan is unlikely to help you.
  • If you're scannedIt shows what you have now, which is more than a risk estimate can do. It does not yet tell you that acting on it prevents a heart attack.
  • Tracking over timeGuidance suggests years rather than months between scans, and how quickly plaque really changes is not well established.
This is one expert's perspective. The full topic shows where experts agree and disagree.Explore full topic →